AUG 26, 2018 06:53 PM PDT

Why the Same Genetic Mutation can Affect People Differently

WRITTEN BY: Carmen Leitch

Scientists have been confounded for years by genetic errors that had the same sequence but exert a varied effect in different individuals. The same mutation may cause a disease like breast cancer, Huntington's disease or retinoblastoma, while having different levels of severity, or variable penetrance, in patients. Now, scientists at the New York Genome Center (NYGC) and Columbia University have proposed a mechanism for that effect; they have reported their findings in Nature Genetics.

Most genes code for proteins that carry out cellular functions. Some genes, however, act to regulate the expression of those protein-coding genes. This work has found evidence that variations in those regulatory genes are connected with the variable effects of disease-causing mutations, which has implications for many disorders. This work was led by post-doctoral research fellow Dr. Stephane Castel and Dr. Tuuli Lappalainen, Assistant Professor at Columbia University Department of Systems Biology and NYGC Core Faculty Member.

“Our findings suggest that a person’s disease risk is potentially determined by a combination of their regulatory and coding variants, and not just one or the other,” Lappalainen explained. “Most previous studies have focused on either looking for coding variants or regulatory variants that affect disease in these individuals or potentially looking at common variants that could affect disease. We have merged these two fields into one clear hypothesis that uses data from both of them, which was fairly unheard of before.”

To test whether variable penetrance was linked to gene regulation,  Lappalainen’s team queried a large dataset of genetic variants that impact human gene expression - the Genotype-Tissue Expression (GTEx) project. That enabled them to identify combinations of variants in regulatory and coding genes that were protective against disease. The scientists weren’t surprised to find that natural selection was weeding out gene variants that were damaging to human health, Castel noted.

Following up on this work in patients, the investigators utilized data in The Cancer Genome Atlas (TCGA) from the National Institutes of Health, and a repository of familial genetic data that included children with autism spectrum disorder. The scientists found that patients with cancer and individuals with autism carried more genetic combinations that promoted the penetrance of their disease.

In a final test of their hypothesis, the researchers used gene editing to change a gene linked to a rare, hereditary disease that increases tumor risk, called Birt-Hogg-Dubé Syndrome. By changing a regulatory gene, the team modified the effect of the mutation that causes the disease. This work shows, therefore, that there is a way to assess gene variants that have been connected to disease, to see how detrimental they are when combined with certain changes in regulatory genes.

“Now that we have demonstrated a mechanism for modified penetrance, the long-term goal of the research is better prediction of whether an individual is going to have a disease using their genetic data by integrating the regulatory and coding variants,” Lappalainen said.

“In future, studies of the genetic causes of severe diseases should take into account this idea that regulatory variants need to be considered alongside coding variants,” added Castel. “This should eventually lead to a more fine-grained understanding of the risk of coding variants associated with disease.”

Learn more about variable penetrance from the video.

Sources: New York Genome Center, Nature Genetics

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 12, 2018
Cell & Molecular Biology
NOV 12, 2018
A New Look at Messenger RNA
Researchers have discovered that longstanding textbook knowledge about an important molecule called mRNA is probably incorrect....
DEC 04, 2018
Genetics & Genomics
DEC 04, 2018
The Fallout From the First CRISPR Babies Continues
Last week the world was stunned to hear that twin babies had been born after a gene-editing experiment was conducted on human embryos....
DEC 12, 2018
Cell & Molecular Biology
DEC 12, 2018
Keeping Stem Cells in a State of Unlimited Potential
Researchers have discovered a molecule that can put the brakes on the development of embryonic stem cells....
DEC 28, 2018
Videos
DEC 28, 2018
What is Sanger Sequencing?
You may have heard of Sanger sequencing, a common tool used in the genetics laboratory to decode the sequence of a strand of DNA....
JAN 05, 2019
Cell & Molecular Biology
JAN 05, 2019
The Body's Largest Cellular Receptor is Identified
The structure of a huge receptor in the body, which binds to vitamin B12, has now been elucidated....
JAN 15, 2019
Immunology
JAN 15, 2019
Decipher the Clues with CRISPR
Scientists have created the first retroviral CRISPR-Cas9 gene editing library to explore the regulation of mouse T cells, which are key cells in the immune system. Researchers mapped the most...
Loading Comments...